Reyataz and Dacryoadenitis acquired - from FDA reports
There is no Dacryoadenitis acquired reported by people who take Reyataz yet. This review analyzes which people have Dacryoadenitis acquired with Reyataz. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Dec, 16, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Dacryoadenitis acquired when taking Reyataz?
- Check symptoms - is dacryoadenitis acquired caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Join related support groups - you are not alone, join a support group on ehealth.me
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- write a review - share your experience related to the study
- More tools...
Expand the study to include all drugs with the same ingredientsDacryoadenitis acquired and drugs with ingredients of atazanavir sulfate.
Expand the study to include reports from both FDA and eHealthMeDacryoadenitis acquired and Reyataz from FDA and eHealthMe reports
Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. (latest outcomes from Reyataz 8,724 users)
Dacryoadenitis acquired (inflammation of the lacrimal glands acquired) has been reported by people with hepatitis c, high blood pressure, hyperthyroidism, rheumatoid arthritis, sialoadenitis (latest reports from 28 Dacryoadenitis acquired patients).